Michael Scott Mann Insider Profile
4 Followers
Michael Scott Mann, President at Endonovo Therapeutics, holds 26.79M shares in Endonovo Therapeutics (Ticker: ENDV). Most recently, Michael Scott Mann Bought 5,000 shares of Endonovo Therapeutics on Apr 09, 2019 for an estimated value of $50.00.
Michael Scott Mann's Trading History
| ENDVEndonovo Therapeutics | Apr 09, 2019 | President | Informative Buy | 50.00 | ― | |
ENDV Insider Shares: 26.79M (3.21%) | ||||||
You May Also Like
Michael Scott Mann insider profile FAQ
What is the percentage of profitable transactions made by Michael Scott Mann?
The percentage of profitable transactions made by Michael Scott Mann is 0%.
What is the average return per transaction made by Michael Scott Mann?
The average return per transaction made by Michael Scott Mann is -96.20%.
What stocks does Michael Scott Mann hold?
Michael Scott Mann holds: ENDV stocks.
What was Michael Scott Mann’s latest transaction?
Michael Scott Mann’s latest transaction was an Informative Buy of $50.00.
What was Michael Scott Mann's most profitable transaction?
Michael Scott Mann’s most profitable transaction was an Informative Buy of ENDV stock on January 3, 2019. The return on the trade was -91.90%.
What is Michael Scott Mann's role in Endonovo Therapeutics?
Michael Scott Mann's role in Endonovo Therapeutics is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
